$PTCT News

Jefferies Upgrades PTC Therapeutics to Buy, Raises Price Target to $85

PTC Therapeutics, Inc. (PTCT) Presents at Bank of America Global Healthcare Conference 2026 Transcript

PTC Therapeutics: Sephience Turns The Story From Regulatory Repair To Operating Leverage

PTC Therapeutics Q1 Earnings Call Highlights

TD Cowen Upgrades PTC Therapeutics to Buy, Raises Price Target to $90

RBC Capital Maintains Sector Perform on PTC Therapeutics, Raises Price Target to $82

PTC Therapeutics, Inc. Q1 2026 Earnings Call Summary

Wells Fargo Maintains Overweight on PTC Therapeutics, Raises Price Target to $95

PTC Therapeutics, Inc. (PTCT) Q1 2026 Earnings Call Transcript

Compared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics

PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates

PTC Therapeutics Inc (NASDAQ:PTCT) Delivers Q1 Earnings Beat and Raises 2026 Guidance

PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results

PTC Therapeutics Raises FY2026 Sales Guidance from $700.000M-$800.000M to $1.080B-$1.180B vs $1.013B Est

PTC Therapeutics Q1 EPS $(0.03) Beats $(0.48) Estimate, Sales $272.551M Beat $218.805M Estimate

Global RNA Targeting Small Molecule Drug Discovery Market Size/Share Worth USD 17.6 Billion by 2035 at a 22.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)

Exploring Analyst Estimates for PTC Therapeutics (PTCT) Q1 Earnings, Beyond Revenue and EPS

Assessing PTC Therapeutics (PTCT) Valuation After Encouraging New Huntington’s Disease Data

How The PTC Therapeutics (PTCT) Story Is Shifting With Sephience And Franchise Pressures

Agenus (AGEN) Earnings Expected to Grow: What to Know Ahead of Q1 Release